The APHB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APHB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The APHB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View APHB Detailed Price Forecast - CNN Money||View APHB Detailed Summary - Google Finance|
|View APHB Detailed Summary - Yahoo! Finance||View APHB Stock Research & Analysis - Zacks.com|
|View APHB Trends & Analysis - Trade-Ideas||View APHB Major Holders - Barrons|
|View APHB Call Transcripts - NASDAQ||View APHB Breaking News & Analysis - Seeking Alpha|
|View APHB Annual Report - CompanySpotlight.com||View APHB OTC Short Report - OTCShortReport.com|
|View APHB Fundamentals - TradeKing||View APHB SEC Filings - Bar Chart|
|View Historical Prices for APHB - The WSJ||View Performance/Total Return for APHB - Morningstar|
|View the Analyst Estimates for APHB - MarketWatch||View the Earnings History for APHB - CNBC|
|View the APHB Earnings - StockMarketWatch||View APHB Buy or Sell Recommendations - MacroAxis|
|View the APHB Bullish Patterns - American Bulls||View APHB Short Pain Metrics - ShortPainBot.com|
|View APHB Stock Mentions - StockTwits||View APHB Stock Mentions - PennyStockTweets|
|View APHB Stock Mentions - Twitter||View APHB Investment Forum News - Investor Hub|
|View APHB Stock Mentions - Yahoo! Message Board||View APHB Stock Mentions - Seeking Alpha|
|View Insider Transactions for APHB - SECform4.com||View Insider Transactions for APHB - Insider Cow|
|View APHB Major Holdings Summary - CNBC||View Insider Disclosure for APHB - OTC Markets|
|View Insider Transactions for APHB - Yahoo! Finance||View Institutional Holdings for APHB - NASDAQ|
|View APHB Stock Insight & Charts - FinViz.com||View APHB Investment Charts - StockCharts.com|
|View APHB Stock Overview & Charts - BarChart||View APHB User Generated Charts - Trading View|
How Much Of AmpliPhi Biosciences Corporation (NYSEMKT:APHB) Do Institutions Own?
Posted on Monday November 12, 2018
The big shareholder groups in AmpliPhi Biosciences Corporation (NYSEMKT:APHB) have power over the company. Institutions often own shares in more established companies, while it’s not unusual to see insiders own
AmpliPhi Biosciences Reports Third Quarter 2018 Financial Results and Business Highlights
Posted on Thursday November 08, 2018
SAN DIEGO-- -- The company intends to initiate one or more clinical trials in 2019 following positive FDA feedback Announced positive updated results from the company’s expanded access program: 21 patients with serious or life-threatening infections were treated at 7 hospitals, with 84% treatment success at the end of therapy Raised gross proceeds of $6.8 million through an underwritten public offering ...
AmpliPhi Biosciences Announces Closing of Public Offering
Posted on Tuesday October 16, 2018
AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for patients with serious and life-threatening antibiotic-resistant bacterial infections, today announced the closing of its previously announced underwritten public offering. AmpliPhi sold 17,000,000 shares of common stock, or pre-funded warrants in lieu thereof, including 462,500 shares sold pursuant to the partial exercise of the underwriter’s option to purchase additional shares, and common warrants to purchase 17,500,000 shares of common stock, including common warrants to purchase 962,500 shares sold pursuant to the underwriter’s partial exercise of its option to purchase additional common warrants.
AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering
Posted on Friday October 12, 2018
AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for patients with serious and life-threatening antibiotic-resistant bacterial infections, today announced the pricing of an underwritten public offering of 16,537,500 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof), and common warrants to purchase up to an aggregate of 16,537,500 shares of common stock. Each share of common stock and, as applicable, pre-funded warrant is being sold together with a common warrant to purchase one share of common stock at a combined effective price to the public of $0.40 per share and accompanying common warrant.